Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Mirtti

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Plos One|December 28, 2017
Repeat multiparametric MRI in prostate cancer patients on active surveillanceJuho T Eineluoto, Petrus Järvinen, Anu Kenttämies, et al.
Cell Death Discovery|November 6, 2025
Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilitiesFrida Rantanen, Astrid Murumägi, Mariliina Arjama, et al.
The Prostate|March 18, 2021
Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancersTimo-Pekka K Lehto, Carolin Stürenberg, Adrian Malén, et al.
Cancer Research|August 18, 2010
FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cellsSantosh Gupta, Kristiina Iljin, Henri Sara, et al.
European Urology Oncology|May 18, 2019
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter StudyAndrew M Erickson, Stefano Luzzago, Axel Semjonow, et al.
Research Square|December 3, 2025
Estrogen Metabolism Pathways in Pregnancy and Subsequent Breast Cancer Risk: A Prospective Follow-up StudyRebecca Troisi, Roni Falk, Helja-Marja Surcel, et al.
Developmental Cell|February 3, 2015
Rac1 nucleocytoplasmic shuttling drives nuclear shape changes and tumor invasionInmaculada Navarro-Lérida, Teijo Pellinen, Susana A Sanchez, et al.
International Journal of Cancer|September 28, 2023
Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosisTimo-Pekka K Lehto, Juho Pylväläinen, Kevin Sandeman, et al.
BJU International|December 15, 2025
Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancerAbderrahim-Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
The Prostate|July 8, 2020
PTEN and ERG expression in MRI-ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancerAndrew M Erickson, Utku Lokman, Kanerva Lahdensuo, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Plos One|December 28, 2017
Repeat multiparametric MRI in prostate cancer patients on active surveillanceJuho T Eineluoto, Petrus Järvinen, Anu Kenttämies, et al.
Cell Death Discovery|November 6, 2025
Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilitiesFrida Rantanen, Astrid Murumägi, Mariliina Arjama, et al.
The Prostate|March 18, 2021
Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancersTimo-Pekka K Lehto, Carolin Stürenberg, Adrian Malén, et al.
Cancer Research|August 18, 2010
FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cellsSantosh Gupta, Kristiina Iljin, Henri Sara, et al.
European Urology Oncology|May 18, 2019
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter StudyAndrew M Erickson, Stefano Luzzago, Axel Semjonow, et al.
Research Square|December 3, 2025
Estrogen Metabolism Pathways in Pregnancy and Subsequent Breast Cancer Risk: A Prospective Follow-up StudyRebecca Troisi, Roni Falk, Helja-Marja Surcel, et al.
Developmental Cell|February 3, 2015
Rac1 nucleocytoplasmic shuttling drives nuclear shape changes and tumor invasionInmaculada Navarro-Lérida, Teijo Pellinen, Susana A Sanchez, et al.
International Journal of Cancer|September 28, 2023
Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosisTimo-Pekka K Lehto, Juho Pylväläinen, Kevin Sandeman, et al.
BJU International|December 15, 2025
Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancerAbderrahim-Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
The Prostate|July 8, 2020
PTEN and ERG expression in MRI-ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancerAndrew M Erickson, Utku Lokman, Kanerva Lahdensuo, et al.
Pageof 13